PARP inhibition causes replication stress in preclinical models of high risk neuroblastoma and synergises with inhibition of ATR

被引：0
|
作者：
Southgate, Harriet [1 ]
Curtin, Nicola J. [1 ]
Tweddle, Deborah A. [1 ]
机构：
[1] Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
来源：
BRITISH JOURNAL OF CANCER | 2019年 / 121卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
57
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [11] DNA damage response deficiency enhances neuroblastoma progression and sensitivity to combination PARP and ATR inhibition
    Hayes, Madeline N.
    Cohen-Gogo, Sarah
    Kee, Lynn
    Layeghifard, Mehdi
    Valencia-Sama, Ivette
    Rajaselvam, Anisha
    Kaplan, David
    Villani, Anita
    Shlien, Adam
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    CANCER RESEARCH, 2024, 84 (17)
  • [12] ATR inhibition rewires cellular signaling networks induced by replication stress
    Wagner, Sebastian A.
    Oehler, Hannah
    Voigt, Andrea
    Dalic, Denis
    Freiwald, Anja
    Serve, Hubert
    Beli, Petra
    PROTEOMICS, 2016, 16 (03) : 402 - 416
  • [13] Targeting the ATR/CHK1 axis in combination with PARP inhibition is more effective than PARP inhibition alone in BRCA mutant models
    George, Erin
    Kim, Hyoung
    Tanyi, Janos
    Ragland, Ryan
    Zhang, Rugang
    Bradford, Patricia
    Krepler, Clemens
    Nathanson, Katherine
    Wenz, Brandon
    Lu, Yiling
    Mills, Gordon
    Morgan, Mark
    Simpkins, Fiona
    CANCER RESEARCH, 2016, 76
  • [14] MEK 1/2 inhibition and biomarkers of response in preclinical models of neuroblastoma
    Hart, Lori S.
    Batra, Vandana
    Raman, Pichai
    Gagliardi, Maria
    Rader, JulieAnn
    Chen, Lucy
    Fritsch, Christine
    Caponigro, Giordano
    Peters, Malte
    Boehm, Markus
    Maris, John M.
    CANCER RESEARCH, 2014, 74 (20)
  • [15] Glutaminase inhibition induces replication stress in ovarian cancer cells and inhibition of replication checkpoint causes synthetic lethality
    Luna, Pamela
    Acharya, Ganesh
    Ochola, Damieanus
    Peddibhotla, Swetha
    Mani, Chinnadurai
    Reedy, Mark B.
    Palle, Komaraiah
    CANCER RESEARCH, 2023, 83 (07)
  • [16] PRMT blockade induces defective DNA replication stress response and with PARP inhibition
    Li, Yang
    Dobrolecki, Lacey E.
    Sallas, Christina
    Zhang, Xudong
    Kerr, Travis D.
    Bisht, Deepa
    Wang, Yalong
    Awasthi, Sharad
    Kaundal, Babita
    Wu, Siqi
    Peng, Weiyi
    Mendillo, Marc L.
    Lu, Yiling
    Jeter, Collene R.
    Peng, Guang
    Liu, Jinsong
    Westin, Shannon N.
    Sood, Anil K.
    Lewis, Michael T.
    Das, Jishnu
    Yi, S. Stephen
    Bedford, Mark T.
    Mcgrill, Daniel J.
    Sahni, Nidhi
    CELL REPORTS MEDICINE, 2023, 4 (12)
  • [17] Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models
    Morowitz, MJ
    Barr, R
    Wang, Q
    King, R
    Rhodin, N
    Pawel, B
    Zhao, HQ
    Erickson, SA
    Sheppard, GS
    Wang, JY
    Maris, JM
    Shusterman, S
    CLINICAL CANCER RESEARCH, 2005, 11 (07) : 2680 - 2685
  • [18] Therapeutic targeting of KSP in preclinical models of high-risk neuroblastoma
    Hansson, Karin
    Radke, Katarzyna
    Aaltonen, Kristina
    Saarela, Jani
    Manas, Adriana
    Sjolund, Jonas
    Smith, Emma M.
    Pietras, Kristian
    Pahlman, Sven
    Wennerberg, Krister
    Gisselsson, David
    Bexell, Daniel
    SCIENCE TRANSLATIONAL MEDICINE, 2020, 12 (562)
  • [19] DNA-PK inhibition releases PARP inhibitor-induced DNA replication stress
    Sunada, Shigeaki
    Miki, Yoshio
    CANCER SCIENCE, 2018, 109 : 833 - 833
  • [20] Targeting the ATR-Chk1 axis with PARP inhibition results in tumor regression in BRCA mutant models
    George, E.
    Kim, H.
    Ragland, R.
    Rafail, S.
    Zhang, R.
    Krepler, C.
    Morgan, M. A.
    Herlyn, M.
    Brown, E.
    Simpkins, F.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 100 - 100
12345